Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer

Staging of Advanced Ovarian Cancer: Comparison of Imaging Modalities—Report from the Radiological Diagnostic Oncology Group

Clare M. Tempany, Kelly H. Zou, Stuart G. Silverman et al. · Radiology · 2000 · 381 citations

Medicine, Oncology, Radiology +17

Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT

Robert E. Bristow, Marcela G. del Carmen, Harpreet K. Pannu et al. · Gynecologic Oncology · 2003 · 194 citations

Medicine, Oncology, Surgery +16

Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)

Karl F. Hübner, Thomas W. McDonald, John G. Niethammer et al. · Gynecologic Oncology · 1993 · 177 citations

Medicine, Nuclear Medicine, Oncology +14

Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma

R. Huch, W. Dörffler, Gustav K. von Schulthess et al. · European Radiology · 2000 · 166 citations

Medicine, Oncology, Radiology +16

Incremental Benefits of FDG Positron Emission Tomography over CT Alone for the Preoperative Staging of Ovarian Cancer

Yoshio Yoshida, Tetsuji Kurokawa, Kazumi Kawahara et al. · American Journal of Roentgenology · 2004 · 159 citations

Medicine, Oncology, Radiology +15